Fact CheckerSign in

NCT04688710Completed

Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 17 May 2024

Brief summary (registry, in English)

The purpose of this study is to assess the effectiveness of two self-guided psychological treatments, Self-Hypnosis (HYP) and Mindfulness Meditation (MM) compared to Treatment as Usual (TAU) for people with multiple sclerosis (MS) and clinically significant fatigue.

Status (registry)
Completed
Study type
Interventional
Enrollment
333 (actual)
First submitted
23 Dec 2020
Start date
30 Apr 2021
Primary completion date
27 Jun 2023
Lead sponsor
University of Washington
NCT number
NCT04688710

What you commit to

  • Study type: Interventional
  • Participants enrolled: 333
  • From 30 Apr 2021 to the primary completion date, 27 Jun 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently receiving psychological treatment for fatigue more than once per month.
  • Has received mindfulness meditation or hypnosis training in the past and has practiced mindfulness meditation/hypnosis in the past three months.

Other illness

  • Psychiatric condition or symptoms that would interfere with participation, specifically (a) current active suicidal ideation with current intent to harm oneself, (b) current psychosis, or (c) current mania.

Who the study is looking for

  • Self-reported diagnosis of MS.
  • Age 18 years old or older at the time of study enrollment.
  • Presenting with clinically meaningful fatigue (i.e., reporting daily fatigue ≥50% of the days in the past 6 months with an average severity in the past week of ≥ 20 on the PROMIS Fatigue short form \[T-score, 56.4\]).
  • Able to read, speak, and understand English.
  • Access to an internet-enabled device (desktop/laptop/tablet/smart phone) to allow access to the recordings and to complete the study measures via the internet.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UW Medicine Multiple Sclerosis Center
Coordinator of this site? Confirm its status
SeattleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.